DK1558935T3 - Præparater med styret afgivelse - Google Patents
Præparater med styret afgivelseInfo
- Publication number
- DK1558935T3 DK1558935T3 DK03809236T DK03809236T DK1558935T3 DK 1558935 T3 DK1558935 T3 DK 1558935T3 DK 03809236 T DK03809236 T DK 03809236T DK 03809236 T DK03809236 T DK 03809236T DK 1558935 T3 DK1558935 T3 DK 1558935T3
- Authority
- DK
- Denmark
- Prior art keywords
- matrix
- release
- agent
- controlled release
- release preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50906202P | 2002-10-25 | 2002-10-25 | |
| US28102602A | 2002-10-25 | 2002-10-25 | |
| PCT/CA2003/001637 WO2004038428A2 (en) | 2002-10-25 | 2003-10-27 | Controlled-release compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1558935T3 true DK1558935T3 (da) | 2008-11-17 |
Family
ID=34976756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03809236T DK1558935T3 (da) | 2002-10-25 | 2003-10-27 | Præparater med styret afgivelse |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1558935B1 (pt) |
| JP (1) | JP2006507276A (pt) |
| KR (1) | KR101120729B1 (pt) |
| AT (1) | ATE400819T1 (pt) |
| AU (1) | AU2003275854B9 (pt) |
| BR (1) | BR0315657A (pt) |
| CA (1) | CA2503361C (pt) |
| DE (1) | DE60322091D1 (pt) |
| DK (1) | DK1558935T3 (pt) |
| EC (1) | ECSP055748A (pt) |
| ES (1) | ES2310686T3 (pt) |
| HK (1) | HK1086475A1 (pt) |
| MX (1) | MXPA05004410A (pt) |
| NO (1) | NO20052515L (pt) |
| NZ (1) | NZ539869A (pt) |
| PT (1) | PT1558935E (pt) |
| RU (1) | RU2333745C2 (pt) |
| SI (1) | SI1558935T1 (pt) |
| WO (1) | WO2004038428A2 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
| US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
| US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| JP2005306778A (ja) * | 2004-04-21 | 2005-11-04 | Basf Ag | 徐放性製剤及びその製造方法 |
| JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | Ｐｐｉ多回剤形 |
| CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
| EP1917000A2 (en) | 2005-07-07 | 2008-05-07 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
| ES2389666T3 (es) * | 2005-09-09 | 2012-10-30 | Angelini Labopharm, Llc | Composición de trazodona para una administración de una vez al día |
| CN100437113C (zh) * | 2006-04-11 | 2008-11-26 | 汪运山 | 一种检测血液中非那西丁与醋氨酚浓度比值的试剂盒 |
| AU2013202441B2 (en) * | 2006-04-26 | 2016-02-25 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
| HUE029173T2 (hu) | 2006-04-26 | 2017-02-28 | Alphapharm Pty Ltd | Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot |
| CN100387988C (zh) * | 2006-07-25 | 2008-05-14 | 山东省医药工业研究所 | 一种布洛伪麻那敏复方制剂的含量检测方法 |
| AU2008213744B2 (en) | 2007-02-09 | 2013-12-05 | Alphapharm Pty Ltd | A dosage form containing two or more active pharmaceutical ingredients in different physical forms |
| MX336494B (es) | 2007-10-16 | 2016-01-21 | Paladin Labs Inc | Composicion de bicapas para la liberacion controlada de acetaminofeno y tramadol. |
| PT2293794E (pt) | 2008-05-27 | 2013-07-10 | Univ Melbourne | Métodos de tratamento de mamíferos com disfunções da trompa de eustáquio |
| EP2448406B1 (en) | 2009-02-26 | 2016-04-20 | Relmada Therapeutics, Inc. | Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use |
| EP2488029B1 (en) | 2009-09-30 | 2016-03-23 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
| EP2563349A4 (en) * | 2010-04-23 | 2014-03-19 | Paladin Labs Inc | NON-INTRAVENOUS-MODIFIED FORM COMPRISING A SOLID FORMULATION OF A BIOLOGICALLY ACTIVE LIQUID AGENT AND USES THEREOF |
| RU2451680C1 (ru) | 2011-02-21 | 2012-05-27 | Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" | Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство |
| CN104968333B (zh) | 2012-11-30 | 2018-07-10 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
| WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
| CN114177155B (zh) * | 2020-09-08 | 2023-10-03 | 越洋医药开发(广州)有限公司 | 一种布洛芬控释片及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109460A (en) * | 1993-05-10 | 1998-03-10 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
| DE19530575A1 (de) * | 1995-08-19 | 1997-02-20 | Gruenenthal Gmbh | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz |
| CA2173818A1 (fr) * | 1996-04-10 | 1997-10-11 | Francois Chouinard | Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose |
| CA2270975C (en) * | 1997-07-02 | 2003-04-01 | Euro-Celtique, S.A. | Stabilized sustained release tramadol formulations |
| US6284273B1 (en) * | 1998-02-24 | 2001-09-04 | Vincent Lenaerts | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
| DE10014588A1 (de) * | 2000-03-27 | 2001-10-04 | Basf Ag | Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung |
| DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
| US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| EP1248599B1 (de) * | 2001-01-31 | 2007-12-05 | Evonik Röhm GmbH | Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen |
-
2003
- 2003-10-27 RU RU2005115883/15A patent/RU2333745C2/ru not_active IP Right Cessation
- 2003-10-27 DE DE60322091T patent/DE60322091D1/de not_active Expired - Lifetime
- 2003-10-27 EP EP03809236A patent/EP1558935B1/en not_active Expired - Lifetime
- 2003-10-27 NZ NZ539869A patent/NZ539869A/en not_active IP Right Cessation
- 2003-10-27 KR KR1020057007088A patent/KR101120729B1/ko active IP Right Grant
- 2003-10-27 WO PCT/CA2003/001637 patent/WO2004038428A2/en active IP Right Grant
- 2003-10-27 JP JP2004545654A patent/JP2006507276A/ja not_active Withdrawn
- 2003-10-27 AT AT03809236T patent/ATE400819T1/de active
- 2003-10-27 SI SI200331377T patent/SI1558935T1/sl unknown
- 2003-10-27 CA CA2503361A patent/CA2503361C/en not_active Expired - Fee Related
- 2003-10-27 DK DK03809236T patent/DK1558935T3/da active
- 2003-10-27 AU AU2003275854A patent/AU2003275854B9/en not_active Expired
- 2003-10-27 BR BR0315657-5A patent/BR0315657A/pt active IP Right Grant
- 2003-10-27 PT PT03809236T patent/PT1558935E/pt unknown
- 2003-10-27 ES ES03809236T patent/ES2310686T3/es not_active Expired - Lifetime
- 2003-10-27 MX MXPA05004410A patent/MXPA05004410A/es active IP Right Grant
-
2005
- 2005-04-25 EC EC2005005748A patent/ECSP055748A/es unknown
- 2005-05-25 NO NO20052515A patent/NO20052515L/no not_active Application Discontinuation
-
2006
- 2006-06-02 HK HK06106374A patent/HK1086475A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101120729B1 (ko) | 2012-04-23 |
| PT1558935E (pt) | 2008-10-16 |
| EP1558935A2 (en) | 2005-08-03 |
| RU2333745C2 (ru) | 2008-09-20 |
| CA2503361A1 (en) | 2004-05-06 |
| WO2004038428A3 (en) | 2005-06-09 |
| NZ539869A (en) | 2007-09-28 |
| EP1558935B1 (en) | 2008-07-09 |
| NO20052515D0 (no) | 2005-05-25 |
| CA2503361C (en) | 2012-02-28 |
| KR20050088281A (ko) | 2005-09-05 |
| RU2005115883A (ru) | 2006-01-27 |
| HK1086475A1 (en) | 2006-09-22 |
| WO2004038428A2 (en) | 2004-05-06 |
| BR0315657A (pt) | 2005-09-13 |
| SI1558935T1 (sl) | 2008-12-31 |
| DE60322091D1 (de) | 2008-08-21 |
| AU2003275854B2 (en) | 2008-09-11 |
| ECSP055748A (es) | 2005-08-11 |
| ATE400819T1 (de) | 2008-07-15 |
| MXPA05004410A (es) | 2005-11-23 |
| JP2006507276A (ja) | 2006-03-02 |
| AU2003275854A1 (en) | 2004-05-13 |
| ES2310686T3 (es) | 2009-01-16 |
| AU2003275854B9 (en) | 2009-08-27 |
| NO20052515L (no) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052515D0 (no) | Frigjoringskontrollerte sammensetninger | |
| ATE512659T1 (de) | Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie | |
| AR024492A1 (es) | Formas de dosificacion farmaceutica para liberacion controlada que comprenden al menos un impulso ciclico | |
| MX9707585A (es) | Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada. | |
| ME00482B (me) | Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje | |
| TWI235068B (en) | Sustained-release pharmaceutical composition | |
| ATE359075T1 (de) | Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose | |
| DE60132077D1 (de) | Vitaminzusammenstellung mit verzögerter freigabe | |
| TR200102880T2 (tr) | Enjekte edilebilir naltrekson mikrokre bileçimleri ve bunlarìn eroin ve alkol tketiminin azaltìmì iin kullanìmì | |
| JO2555B1 (en) | Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent | |
| BR0215262A (pt) | Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas | |
| GEP20074022B (en) | Pharmaceutical formulations comprising oxycodone and naloxone | |
| DE60233760D1 (de) | Netzwerkeinrichtungs-treiberarchitektur | |
| WO2004064815A8 (en) | Oral dosage formulation | |
| DE69229881D1 (de) | Tablette mit verzögerter freisetzung | |
| AR020610A1 (es) | Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero | |
| IE881195L (en) | Ibuprofen sustained release matrix | |
| ME00391B (me) | Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem | |
| CO5680108A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| DE69925639D1 (de) | Glicazidhaltige matrixtablette mit verzögerter wirkstoffverabreichung zur oralen anwendung | |
| ATE185266T1 (de) | Schnell auflösende orale darreichungsform | |
| MY142195A (en) | Controlled-release compositions | |
| UA86929C2 (ru) | Композиция с контролируемым высвобождением | |
| DE69627365D1 (de) | Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten | |
| BRPI0315657B8 (pt) | formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição |